Vmbook Online ordering

Drug Delivery

Alaska Air Group (ALKS) is not a public company focused on drug delivery. It is a holding company for Alaska Airlines and Horizon Air, which are regional airlines based in the United States. Therefore, I cannot provide the information you are looking for.

However, if you are looking for a public company that is focused on drug delivery, one option you might consider is Alkermes Plc (ALKS), which is a biopharmaceutical company focused on the development and commercialization of medicines to treat central nervous system (CNS) diseases and addictions.

As of February 10, 2023, the company's market capitalization is approximately $4.3 billion, and its stock price is around $18.80 per share. Over the past 52 weeks, the stock has traded in a range of $16.02 to $28.52 per share.

In terms of earnings, Alkermes reported revenue of $354.2 million for the full year 2021, representing an increase of 15% compared to the prior year. The company's net loss for the year was $44.3 million, or $0.27 per share, which was an improvement compared to a net loss of $135.6 million, or $0.90 per share, in 2020.

In terms of growth, Alkermes has several potential catalysts for growth in the coming years. The company's lead drug candidate, ALKS 3831, for the treatment of schizophrenia, is in phase 3 clinical trials and has the potential to be a blockbuster drug if approved by regulatory authorities. Additionally, Alkermes has a strong pipeline of other CNS drug candidates in various stages of development, including drug candidates for the treatment of addiction and depression.

However, it is important to note that investing in the stock market always carries risk, and it is important to do your own research and consult with a financial advisor before making any investment decisions.

    Insider healthcare drug-delivery alks index